Posted on 2/11/21
Ortho Clinical Diagnostics: What You Need to Know
In this episode of Industry Focus: Wildcard, host Jason Moser and Motley Fool contributor Brian Feroldi take a closer look at Ortho Clinical Diagnostics' (NASDAQ:OCDX) debut . . .
Posted on 2/11/21
Is Moderna Stock Overvalued?
Moderna(NASDAQ:MRNA) stock skyrocketed last year. Its momentum has carried over into 2021 as well. After its tremendous gains, the biotech's market cap is now well over . . .
Posted on 2/11/21
Can KalVista Pharmaceuticals Stock Fly Higher?
The biotech industry's a wonky place where the outlook for a company's future can, and often does, change overnight. Successful clinical trial results for a potential . . .
Posted on 2/11/21
Bioventus Prices of IPO
DURHAM, N.C., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. today announced the pricing of its initial public offering of 8,000,000 shares of Class A common . . .
Posted on 2/11/21
Onconova Therapeutics Prices of $25 Million Public Offering of Common Stock
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 2/11/21
Ocugen Closes $23M Registered Direct Offering of Common Stock
MALVERN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Nasdaq: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness . . .
Posted on 2/11/21
Bioasis Announces Shares for Debt Transaction
NEW HAVEN, Conn., Feb. 10, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology . . .
Posted on 2/11/21
Prestige Consumer Healthcare Prices $600 Million Senior Notes
TARRYTOWN, N.Y., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. has priced an upsized offering . . .
Posted on 2/11/21
Rhythm Pharmaceuticals Closes $172.5M Public Offering
BOSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 2/11/21
Sensei Biotherapeutics Closes IPO
BOSTON and ROCKVILLE, Md., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation . . .
Posted on 2/11/21
Applied Therapeutics Announces Offering of 3M Shares of Common Stock
NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates . . .
Posted on 2/11/21
KalVista Pharmaceuticals Prices Upsized $193.5M Public Offering of Common Stock
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the pricing of its upsized underwritten public offering of 5,375,000 shares of its common . . .
Posted on 2/11/21
Scopus BioPharma Announces Closing of Underwriters' Over-Allotment Option in Full
Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters' over-allotment option in full, bringing total follow-on public offering proceeds to $10.35 million.Scopus is . . .
Posted on 2/11/21
Maryland has Administered First Vaccine Doses to more than 9% of Residents, Second Doses to 3%
As of Wednesday a total of 570,495 Marylanders have received at least the first dose of the coronavirus vaccine, including 181,541 residents who have received the . . .
Posted on 2/11/21
Maryland Administers More Than 700,000 Vaccine Doses
Maryland providers have administered 727,828 doses of the coronavirus vaccine as of Wednesday morning, including 558,838 first doses and 168,990 second vaccine doses.In the past 24 . . .
Posted on 2/11/21
Holy Cross Health Named in the Top 5 in the U.S. for Shoulder Arthroplasty
Holy Cross Health has been recognized as one of the top five hospitals in the country for shoulder arthroplasty according to Orthopedic News Network, a healthcare . . .
Posted on 2/10/21
Onconova Therapeutics Proposes Public Offering of Common Stock
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, . . .
Posted on 2/10/21
Stealth BioTherapeutics Prices Of $4.7 Million Registered Direct Offering Of American Depositary Shares
Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced . . .
Posted on 2/10/21
Healthcare Services Group Reports Q4 2020 Results
BENSALEM, PA--(BUSINESS WIRE)--Healthcare Services Group, Inc. (NASDAQ:HCSG) reported for the three months ended December 31, 2020 revenue of $423.2 million, net income of $27.7 million, or . . .
Posted on 2/10/21
Biogen Announces the Pricing Terms of its Cash Tender Offer
CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the pricing terms of its previously announced offer to purchase for cash . . .
Posted on 2/10/21
Foothold Technology Acquires Relevant Health Homes
Today, Foothold Technology, a leading cloud-based behavioral health and human services EHR software provider backed by ASG, announced its acquisition of Relevant Health Homes,
Posted on 2/10/21
Catalent Launch of Private Offering of $475 Million of Senior Unsecured Notes
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Posted on 2/10/21
Entity Vor Biopharma Closes $200M IPO
BOSTON--(BUSINESS WIRE)--PureTech Health plc (LSE: PRTC, Nasdaq: PRTC), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased . . .
Posted on 2/10/21
Personal Genome Diagnostics Closes $103 Million Series C
Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of a $103 million Series C financing. The financing was
Posted on 2/10/21
2021's States with the Best & Worst Dental Health - WalletHub Study
With February being National Children’s Dental Health Month and the CDC reporting no COVID-19 transmissions in a clinical dental setting, the personal-finance website WalletHub today released . . .
